Security key
65343E108
NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC)
CUSIP: 65343E108
Q4 2019 13F Holders as of 31 Dec 2019
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 20,192,753
- Total 13F value
- $1,137,417,349
- Share change
- +6,552,944
- Put/Call ratio
- 259%
- SEC-reported price per share
- $56.33
- Number of holders
- 88
- Value change
- +$381,121,391
- Number of buys
- 66
- Number of sells
- 18
- Shares outstanding
- 3,602,511
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q4 2019
Institutions
88
Top holders
10
NXTC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2020
Previous quarter: Q3 2019
NextCure, Inc. SEC filings
NextCure, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 65343E108
Recent filing periods:
Ownership snapshot
Top reported holders of NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Sep 2019
13F
Lead comparable stake: 75%
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 75%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
75%
Sofinnova Investments, Inc.
70%
HHLR ADVISORS, LTD.
29%
CITADEL ADVISORS LLC
26%
Cormorant Asset Management, LP
25%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
75%
|
$83,635,000
2,711,013 shares
|
— | 30 Sep 2019 |
| Sofinnova Investments, Inc. |
13F
Company
|
70%
|
$77,799,000
2,521,856 shares
|
— | 30 Sep 2019 |
| HHLR ADVISORS, LTD. |
13F
Company
|
29%
|
$32,503,000
1,053,570 shares
|
— | 30 Sep 2019 |
| CITADEL ADVISORS LLC |
13F
Company
|
26%
|
$29,047,000
941,557 shares
|
— | 30 Sep 2019 |
| Cormorant Asset Management, LP |
13F
Company
|
25%
|
$27,290,000
884,600 shares
|
— | 30 Sep 2019 |
| ALLIANCEBERNSTEIN L.P. |
13F
Company
|
16%
|
$17,548,000
568,811 shares
|
— | 30 Sep 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
88
Shares
20,192,753
Rows available
88
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
52
Q4 2019 holders
88
Holder diff
36
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 value | Q4 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend